Real-world effectiveness and safety of trastuzumab-deruxtecan in Japanese patients with HER2-positive advanced gastric cancer (EN-DEAVOR study)

Authors

Hisato Kawakami (ORCID: https://orcid.org/0000-0002-3280-4850)
Keita Yamaguchi
Yasuhiro Kodera (ORCID: https://orcid.org/0000-0002-6173-7474)
Hirotaka Konishi (ORCID: https://orcid.org/0000-0002-4899-8944)
Wataru Hashimoto (ORCID: https://orcid.org/0000-0003-0185-2371)
Rin Inamoto
Yukiya Narita (ORCID: https://orcid.org/0000-0002-8018-0077)
Keiko Minashi (ORCID: https://orcid.org/0000-0003-1513-7117)
K. Muro
Naotoshi Sugimoto (ORCID: https://orcid.org/0000-0001-9579-690X)
Akitaka Makiyama (ORCID: https://orcid.org/0000-0002-4017-668X)
Koki Nakanishi (ORCID: https://orcid.org/0000-0002-0629-798X)
Motohiro Imano (ORCID: https://orcid.org/0000-0003-2242-4245)
Satoshi Morita (ORCID: https://orcid.org/0000-0002-4344-3317)
H. Kume

Institutions

Kyoto University (JP)
Kyoto Prefectural University of Medicine (JP)
Daiichi-Sankyo (Japan) (JP)
Gifu University Hospital (JP)
Chiba Cancer Center (JP)
Saitama Cancer Center (JP)
Aichi Cancer Center (JP)
Osaka International Cancer Institute (JP)
Nagoya University (JP)
Kindai University (JP)

Publication Details

Journal: Gastric Cancer
Published: 2024-10-10
DOI: https://doi.org/10.1007/s10120-024-01555-w
Citations: 10
Primary Topic: Gastric Cancer Management and Outcomes
Type: article
Field-Weighted Citation Impact: 4.19

Funders

Daiichi-Sankyo
Daiichi Sankyo Europe

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Real-world effectiveness and safety of trastuzumab-deruxtecan in Japanese patients with HER2-positive advanced gastric cancer (EN-DEAVOR study)

Hisato Kawakami, Keita Yamaguchi, Yasuhiro Kodera, Hirotaka Konishi et al.

Oct 10, 2024

10 citations

Gastric Cancer

Gastric Cancer Management and Outcomes

4.19

article

Real-world effectiveness and safety of trastuzumab-deruxtecan in Japanese patients with HER2-positive advanced gastric cancer (EN-DEAVOR study)

Hisato Kawakami, Keita Yamaguchi, Yasuhiro Kodera, Hirotaka Konishi, Wataru Hashimoto, Rin Inamoto, Yukiya Narita, Keiko Minashi, K. Muro, Naotoshi Sugimoto, Akitaka Makiyama, Koki Nakanishi, Motohiro Imano, Satoshi Morita, H. Kume

October 10, 2024article en

10 citations

Abstract

No abstract available for this paper.

Gastric CancerVol. 28(1)

Kyoto University (JP), Kyoto Prefectural University of Medicine (JP), Daiichi-Sankyo (Japan) (JP), Gifu University Hospital (JP), Chiba Cancer Center (JP), Saitama Cancer Center (JP), Aichi Cancer Center (JP), Osaka International Cancer Institute (JP), Nagoya University (JP), Kindai University (JP)

Daiichi-Sankyo, Daiichi Sankyo Europe

Good health and well-being

Openalex Percentile: Top 5%

Gastric Cancer Management and Outcomes

4.19

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Real-world effectiveness and safety of trastuzumab-deruxtecan in Japanese patients with HER2-positive advanced gastric cancer (EN-DEAVOR study) — Hisato Kawakami, Keita Yamaguchi, et al. · Gastric Cancer (2024) | TGRS Research Map | TGRS